Hisamitsu Pharmaceutical Co., Ltd.
Hisamitsu Pharmaceutical Co., Ltd. is a Private limited company (Ltd.) registered in Japan under 7300001006281, and its current status with National Tax Agency — Corporate Number Publication Site is active. The company was incorporated on 5 October 2015 and lists its registered address as Tosu City, Japan. 5 shareholders are on record for Hisamitsu Pharmaceutical Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from National Tax Agency — Corporate Number Publication Site and was last updated on 28 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Shareholders of Hisamitsu Pharmaceutical Co., Ltd.
Five shareholders are currently on record for Hisamitsu Pharmaceutical Co., Ltd., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing. The largest of these is Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund, holding 9.9% — the largest recorded stake — followed by Goldman Sachs International Small Cap Insights Fund at 4%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data availability
The register reports 11 shareholders in total, though only the top 5 by holding are shown in this view.
Data-provider feed — rows as supplied to Zavia for National Tax Agency — Corporate Number Publication Site, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 9.9% | National Tax Agency — Corporate Number Publication Site | |
| Goldman Sachs International Small Cap Insights Fund | 4% | National Tax Agency — Corporate Number Publication Site | |
| DFA International Core Equity Portfolio | 1.9% | National Tax Agency — Corporate Number Publication Site | |
| Schwab Strategic Tr-Schwab Fundamental Intl Small Company Idx ETF | 1.7% | National Tax Agency — Corporate Number Publication Site | |
| Vanguard International Stock Index-Pacific Stock Index | 1.5% | National Tax Agency — Corporate Number Publication Site |
Officers
5
Directors and officers of Hisamitsu Pharmaceutical Co., Ltd.
The Executive Officer Of Mgmt. Of Internal Audit Division & Domestic Subsidiary Division And Director of Hisamitsu Pharmaceutical Co., Ltd. currently on record is Shinichi Murayama; five officers are currently on record for Hisamitsu Pharmaceutical Co., Ltd., filed with National Tax Agency — Corporate Number Publication Site. Management authority at Hisamitsu Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 14 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Data-provider feed — rows as supplied to Zavia for National Tax Agency — Corporate Number Publication Site, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Group Structure
Group structure of Hisamitsu Pharmaceutical Co., Ltd.
Hisamitsu Pharmaceutical Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 14 subsidiaries recorded beneath it across 9 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- PT HISAMITSU PHARMA INDONESIA (Indonesia)
- TAIYO, K.K. (Japan)
- Hisamitsu America, Inc. (United States)
- HISAMITSU ITALIA SRL (Italy)
- CRCC MEDIA, K.K. (Japan)
- HISAMITSU WELLNESS CO., LTD. (Japan)
- HISAMITSU UK LIMITED (United Kingdom)
- SAGA HISAMITSU SPRINGS CO., LTD. (Japan)
- Hisamitsu Pharmaceutical (Hong Kong) Co., Limited (Hong Kong)
- Jiuguang Pharmaceutical (china) Co., Ltd (China)
Data availability
Those 14 subsidiaries span Japan, Indonesia, United States, Italy, United Kingdom, Hong Kong, and 3 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 14 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Data-provider feed — rows as supplied to Zavia for National Tax Agency — Corporate Number Publication Site, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Hisamitsu Pharmaceutical Co., Ltd.
Japan
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Hisamitsu Pharmaceutical Co., Ltd.?
Five shareholders are currently on record for Hisamitsu Pharmaceutical Co., Ltd., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing. The largest of these is Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund, holding 9.9% — the largest recorded stake — followed by Goldman Sachs International Small Cap Insights Fund at 4%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Hisamitsu Pharmaceutical Co., Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Hisamitsu Pharmaceutical Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Hisamitsu Pharmaceutical Co., Ltd. have on record?
5 shareholders are shown on record for Hisamitsu Pharmaceutical Co., Ltd.. The register reports 11 in total; only the top 5 by holding are shown here.
What is Hisamitsu Pharmaceutical Co., Ltd.'s company registration number?
Hisamitsu Pharmaceutical Co., Ltd.'s registration number is 7300001006281, filed with National Tax Agency — Corporate Number Publication Site in Japan. Its current status on the register is active.
Is Hisamitsu Pharmaceutical Co., Ltd. still an active company?
Hisamitsu Pharmaceutical Co., Ltd.'s status on National Tax Agency — Corporate Number Publication Site is listed as active.
When was Hisamitsu Pharmaceutical Co., Ltd. incorporated?
Hisamitsu Pharmaceutical Co., Ltd. was incorporated on 5 October 2015, according to National Tax Agency — Corporate Number Publication Site.
What is Hisamitsu Pharmaceutical Co., Ltd.'s registered address?
The registered address on file for Hisamitsu Pharmaceutical Co., Ltd. is Tosu City, Japan.
What legal structure is Hisamitsu Pharmaceutical Co., Ltd. registered as?
Hisamitsu Pharmaceutical Co., Ltd. is registered as a Private limited company (Ltd.) in Japan.
Who are the officers/directors of Hisamitsu Pharmaceutical Co., Ltd.?
The Executive Officer Of Mgmt. Of Internal Audit Division & Domestic Subsidiary Division And Director of Hisamitsu Pharmaceutical Co., Ltd. currently on record is Shinichi Murayama; five officers are currently on record for Hisamitsu Pharmaceutical Co., Ltd., filed with National Tax Agency — Corporate Number Publication Site. Management authority at Hisamitsu Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Hisamitsu Pharmaceutical Co., Ltd. have a parent company or subsidiaries?
Hisamitsu Pharmaceutical Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 14 subsidiaries recorded beneath it across 9 jurisdictions. Those 14 subsidiaries span Japan, Indonesia, United States, Italy, United Kingdom, Hong Kong, and 3 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 14 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to Hisamitsu Pharmaceutical Co., Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from National Tax Agency — Corporate Number Publication Site. Zavia's monitoring API can track changes to Hisamitsu Pharmaceutical Co., Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Hisamitsu Pharmaceutical Co., Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Japan, so records like Hisamitsu Pharmaceutical Co., Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from National Tax Agency — Corporate Number Publication Site and was last synced on 28 September 2026.